FAQ'sAbout - PanTum® Detect
What is Pantum® Detect?
PanTum® Detect is a multi-tumor screening blood test that measures levels of two enzyme biomarkers present within your immune cells (macrophages). If the enzyme biomarkers levels are raised the test is positive.
What does the PanTum® Detect blood test detect?
PanTum® Detect test detects the presence of two enzyme biomarkers in whole human blood, which are increasingly formed in all solid tumors – even in the early, asymptomatic phase. The two enzyme biomarkers are called Transketolase-like-1 (TKTL1) and DNaseX (Apo10).
TKTL1 provides an indication of switch towards invasive growth. TKTL1 regulates anaerobic glucose metabolism (Warburg effect) which is fermentation of glucose using the Pentose Phosphate Pathway resulting in the formation of lactic acid and breakdown of collagen matrix leading to metastasis.
DNaseX (Apo10) provides indication of tumor proliferation. Elevated levels of DNaseX (Apo10) enzyme is the result of disruption of programmed cell death (Apoptosis).
Does the test show what type of cancer it is?
No, the test does not show the type, spread or location of the cancer. PanTum® Detect is a screening blood test and a positive result indicates the presence of a tumor if the levels of two enzyme biomarkers are raised. In case of a positive test result, Imaging (PET/CT, MRI) & Pathology diagnostics (Tumor markers, Histopathology / Cytology) are carried out for further confirmatory diagnosis.
The “Cancer-Scan” program combines blood testing with PanTum® Detect and confirmatory techniques (Imaging + Pathology) for those who test positive as an integrated multi-tumor screening concept for early detection of cancer.
Who is excluded from undergoing PanTum® Detect blood test?
Individuals who want to undergo PanTum® Detect need to be in a healthy state to ensure highest blood sample quality.
Following are the inclusion / exclusion criteria for undergoing PanTum Detect blood test.
- Individuals less than 18 years of age.
- Individuals diagnosed with cancer and on active treatment.
- Individuals who have undergone imaging investigation where contrast media has been used (MRI / PET-CT / CT) can undergo this blood test after 1 week.
- Individuals who have suffered from acute bacterial or viral infection (Covid, Acute herpes zoster, Typhoid, Viral hepatitis, etc.) can undergo this blood test after 2 weeks of recovery.
- Individuals who have been administered any vaccination can undergo this blood test after 4 weeks.
- Individuals who are on following medications can undergo this blood test after stopping the medication for 8 weeks.
- Corticosteroid containing drugs
- Immunosuppressants
- Amygdalin
- GMCSF
- Individuals who have suffered from febrile illness or any major surgery or any severe trauma can undergo this blood test after 8 weeks of recovery.
- Individuals in remission (free of cancer and not on any active treatment) for 1 year can undergo this test.
Testimonials That Speak Volumes
“Peace of mind is priceless. I took the PanTum Detect test as part of my annual health checkup.
The process was smooth, just a simple blood draw. Thankfully, it came back clear—but knowing
I had such a comprehensive screening done feels incredibly reassuring.”
Ravi Mehta
⭐⭐⭐⭐⭐
“I was a bit skeptical at first, but after reading up on its accuracy, I went ahead. The test flagged
something abnormal, which led to a follow-up MRI that revealed a very early-stage thyroid
nodule. Grateful for the early alert,
Anita Desai
⭐⭐⭐⭐☆
“As an oncologist, I’ve started recommending PanTum Detect to high-risk patients. The science
behind it is solid, especially as an early warning tool. It should never replace imaging or biopsy,
but as a frontline screen—it’s revolutionary.”
Dr. Sneha Ramesh
⭐⭐⭐⭐⭐
“This test caught my dad’s early-stage lung tumor when he had absolutely no symptoms. Surgery
was successful and recovery is going well. We’re extremely thankful. One star off because we
had to wait 10 days for the results.”
Elizabeth George
⭐⭐⭐⭐☆
“Got this test done during a corporate health camp. It was painless and surprisingly quick. The
report was detailed and highlighted ‘no tumor activity.’ Definitely something every working
professional should consider annually.”
Rahul Chopra
⭐⭐⭐⭐⭐
“The PanTum Detect test is a promising breakthrough, especially for high-risk, asymptomatic
patients. I’ve integrated it into my private practice and seen it help catch early-stage tumors that
would otherwise go unnoticed.
Dr. Alok Menon
⭐⭐⭐⭐⭐
Connect with us for any queries
Connect with us for any queries
Useful Links
Support
Locate Us
© 2023. All rights reserved